[Characteristics of the vascular reactivity in hypertensive NISAG rats].
L A
LA
Balakireva
N A
NA
Makhanova
M N
MN
Nosova
G M
GM
Dymshits
A L
AL
Markel'
G S
GS
Iakobson
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D001012:Aorta, Abdominal / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D001158:Arteries / Q000187:drug effects / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D006973:Hypertension / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D009638:Norepinephrine / Q000494:pharmacology; D018129:Phosphatidylinositol Phosphates / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013315:Stress, Psychological / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D013623:Tail / Q000098:blood supply; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D018129:Phosphatidylinositol Phosphates; D014662:Vasoconstrictor Agents; D009638:Norepinephrine
Kharakteristika sosudistoĭ reaktivnosti gipertenzivnykh krys linii NISAG.